In order to confirm that T cells are required for control of MIF KD tumors, we performed a T cell depletion experiment by treating WT and MIF KD 4T1 tumor-bearing mice with CD4 and CD8 depleting antibodies or isotype control antibodies (cIgG) throughout the course of tumor growth. This evidence concerns the gene CD8A and neoplasm.